Gammadelta Therapeutics Ltd, London
Gammadelta Therapeutics Ltd is a private limited company. Located at 1 Kingdom Street, London W2 6BD, the above-mentioned 7 years old company was incorporated on 2016-06-17 and is officially classified as "research and experimental development on biotechnology" (Standard Industrial Classification: 72110).2 directors can be found in this enterprise: Seyda M. (appointed on 01 August 2022), Emma R. (appointed on 05 April 2022). Among the secretaries (1 in total), we can name: Bryan D. (appointed on 05 April 2022).
About | |
---|---|
Name: Gammadelta Therapeutics Ltd | |
Number: 10238425 | |
Incorporation date: 2016-06-17 | |
End of financial year: 31 March |
Address: |
1 Kingdom Street London W2 6BD |
SIC code: |
72110 - Research and experimental development on biotechnology |
Address | 1-1 Doshomachi 4-Chome Doshomachi 4-Chome, Chuo-Ku, Osaka, 12-10, Japan |
Legal authority | Japan |
Legal form | Corporation |
Country registered | Japan |
Place registered | Japan Exchange Group |
Registration number | 1200-01-077461 |
Nature of control: |
75,01-100% shares 75,01-100% voting rights right to appoint and remove directors |
Address | 50 Lothian Road, Festival Square, Edinburgh, Midlothian, EH3 9WJ, Scotland |
Legal authority | Scottish Law |
Legal form | Private Limited Partnership |
Country registered | Scotland |
Place registered | Companies House Edinburgh |
Registration number | Sl010733 |
Nature of control: |
25-50% voting rights right to appoint and remove directors 25-50% shares |
Address | 38 Jermyn Street, London, SW1Y 6DN, United Kingdom |
Legal authority | England And Wales |
Legal form | Limited Liability Partnership |
Country registered | England And Wales |
Place registered | Registrar Of Companies |
Registration number | Oc320188 |
Nature of control: |
right to appoint and remove directors 25-50% shares |
The deadline for Gammadelta Therapeutics Ltd confirmation statement filing is 2024-06-30. The most current one was sent on 2023-06-16. The date for the next annual accounts filing is 31 December 2023. Latest accounts filing was sent for the time period up until 31 March 2022.
3 persons of significant control are listed in the Companies House, namely: Takeda Pharmaceutical Company Limited owns over 3/4 of shares, 3/4 to full of voting rights. This corporate PSC is located at Doshomachi 4-Chome, Chuo-Ku, 12-10. Abingworth Bioventures Vi Gp Lp owns 1/2 or less of shares, 1/2 or less of voting rights. This corporate PSC is located at Lothian Road, Festival Square, EH3 9WJ Edinburgh, Midlothian. Abingworth Llp owns 1/2 or less of shares. This corporate PSC is located at Jermyn Street, SW1Y 6DN London.
Type | Free download | |
---|---|---|
AA |
Group of companies' report and financial statements (accounts) made up to Thu, 31st Mar 2022 filed on: 3rd, January 2023 | accounts |
Free Download (43 pages) |